AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...
But time is of the essence. This encounter is the result of months of planning and not a small bit of arm-twisting, and it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results